Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Hopes for AIDS Vaccine Still Alive Despite Setbacks


Related Encyclopedia
 border=
Abscess
Acne
Actinomycosis
Acute Myeloid Leukemia (Adult)
More...

Related Healthscout Videos
 border=
Weighted Belt for Autism?
Teaching Old Docs New Tricks
Lead in Soil.
Lead in Soil
More...

Related Animations
 border=
Dental Cavities
Erectile Dysfunction
Menopause
More...

Related Drug Information
 border=
Abilify
Adderal XR
Augmentin
Bactroban Cream
More...

Related News Articles
 border=
Children Aware of Racism
Focusing on School Could Prevent Teen Pregnancies
Report: Young Athletes Need Dual Screening for Heart Defects
Native Tongue Begins in the Womb
More...


Page:  << Prev | 1 | 2 | 3

So, those are the main components of any viable vaccine: a broad immunity against a variety of strains; a two-pronged immune attack that involves antibodies and T-cells; and a "hit-hard, hit-early" approach that stops HIV from setting up it's stronghold in the gut.

And, as Gallo, stressed, "any immune response must last, because we can't vaccinate every couple of months."

The task ahead seems daunting, but progress is being made, the experts said.

Text Continues Below



According to Gallo, his lab at the University of Maryland's Institute of Human Virology has one promising candidate. In primate trials, the vaccine has fulfilled most of the criteria -- except that immunity seems to fade with time.

"If we can solve the problem of keeping immunity going long-term, I'd say it's a candidate-rational vaccine," Gallo said.

Over at the University of Wisconsin, Madison, a group led by pathologist David Watkins has successfully tested a vaccine that has provided monkeys with protection from up to 20 different strains of the simian equivalent of HIV, using only T-cell mediated immunity.

Similar experiments have panned out well in pathologist Louis J. Picker's lab at the Oregon Health & Science University, Koff noted.

At the same time, money continues to pour into HIV vaccine research, either from private industry or from nonprofit sources such as the Bill and Melinda Gates Foundation, IAVI, and the U.S. National Institutes of Health.

The failures of the past have also toughened the science, the experts said.

"Over the past year or two, there have been a lot of calls for a return to basic science, rather than [quickly] testing candidates in people," Johnston said. "It all comes back to a question of doing our homework in basic research, so that we can really come up with a strong candidate that we can have a lot more optimism for."

Gallo agreed.

"There were a number of people in the past who were thinking naively that anything was going to work," he said. HIV has proven much tougher than that, of course. "However, I still believe that a vaccine is do-able, or I wouldn't be working on it," he said.

More information

Find out more about the search for an AIDS vaccine at IAVI.

Page:  << Prev | 1 | 2 | 3

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 12/1/2008

Related Links
 border=
From Healthscout's partner site on diet & exercise, MyDietExercise.com
QUIZ: What's your ideal body weight?
QUIZ: Check your body mass index (BMI) online!
QUIZ: Rate your carbohydrate intake





SOURCES: Wayne Koff, Ph.D., senior vice president, research and development, International AIDS Vaccine Initiative, New York City; Robert Gallo, M.D., director, Institute of Human Virology, University of Maryland School of Medicine, Baltimore; Rowena Johnston, Ph.D., vice president, research, Foundation for AIDS Research (amFAR), New York City


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy